(152 days)
Not Found
No
The device description and performance studies focus on mechanical and material properties, with no mention of AI or ML.
No
The device is described as an oral/enteral syringe intended for the delivery of liquid medication, formula, and breast milk. It does not perform any therapeutic function itself, but rather facilitates the delivery of substances that may or may not be therapeutic.
No
The device is described as a syringe for delivering liquid medication, formula, and breast milk. Its intended use and description focus on delivery and safety features (preventing inadvertent connection to IV systems), not on identifying or diagnosing a condition or disease.
No
The device description clearly states the device is comprised of physical components (barrels, plungers, end caps, pistons) made of specific materials (Polypropylene, Silicone) and includes physical safety connectors. The performance studies also focus on physical characteristics and interactions (Volume Measurement Accuracy, Interface Testing, Size and Material Inspection, Biocompatibility, Sterility, etc.). There is no mention of software as the primary or sole component.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the "delivery of liquid medication, formula, and breast milk." This is a delivery mechanism for substances into the body, not for testing samples from the body to diagnose or monitor a condition.
- Device Description: The description focuses on the physical components and safety features for delivering liquids. There is no mention of reagents, test strips, or any components used for analyzing biological samples.
- Lack of IVD Characteristics: The document does not mention any of the typical characteristics of an IVD, such as:
- Analyzing biological samples (blood, urine, tissue, etc.)
- Detecting specific analytes (proteins, DNA, antibodies, etc.)
- Providing diagnostic or monitoring information
The device is clearly designed for administering substances orally or enterally, which falls under the category of a medical device for delivery, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Oral/Enteral Syringes is intended for the delivery of liquid medication, formula, and breast milk.
Product codes (comma separated list FDA assigned to the subject device)
FPD
Device Description
The Oral/Enteral Syringes are intended for the delivery of liquid medication, formula, and breast milk. The syringes incorporate safety connectors that mate with the Respironics Enteral Only Extension Set, but will not mate with Luer lock or Luer slip fittings. The safety connectors prevent inadvertent connection of the enteral system to an IV system or an IV system to the enteral system. The Oral/Enteral Syringe barrels, plungers and end caps are comprised of Polypropylene, and the pistons are comprised of Silicone.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
The patient population is neonates and infants.
Intended User / Care Setting
The environments for use are hospital and home environments by trained caregivers only.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Design verification tests were performed on the Oral/Enteral Syringes as a result of the risk analysis and product requirements. The following tests were conducted:
- . Volume Measurement Accuracy Testing
- . Enteral Feeding Extension Set Interface Testing
- . Size and Material Inspection
- . Biocompatibility Testing
- . Sterility Testing
- Reliability Inspection .
- . Labeling Inspection
- Environmental Operating Testing .
- . Storage Testing
- . ISTA Testing
Testing Results demonstrated that the Oral/Enteral Syringes meet the required acceptance criteria.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 876.5980 Gastrointestinal tube and accessories.
(a)
Identification. A gastrointestinal tube and accessories is a device that consists of flexible or semi-rigid tubing used for instilling fluids into, withdrawing fluids from, splinting, or suppressing bleeding of the alimentary tract. This device may incorporate an integral inflatable balloon for retention or hemostasis. This generic type of device includes the hemostatic bag, irrigation and aspiration catheter (gastric, colonic, etc.), rectal catheter, sterile infant gavage set, gastrointestinal string and tubes to locate internal bleeding, double lumen tube for intestinal decompression or intubation, feeding tube, gastroenterostomy tube, Levine tube, nasogastric tube, single lumen tube with mercury weight balloon for intestinal intubation or decompression, and gastro-urological irrigation tray (for gastrological use).(b)
Classification. (1) Class II (special controls). The barium enema retention catheter and tip with or without a bag that is a gastrointestinal tube and accessory or a gastronomy tube holder accessory is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I (general controls) for the dissolvable nasogastric feed tube guide for the nasogastric tube. The class I device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 876.9.
0
K100099 Page 1 of 2
Oral/Enteral Syringes
Premarket Notification 510(k) Tab 5 – 510(K) Summary
TAB 5
510(K) SUMMARY
JUN 1 4 2010
| Date of Submission | 11/9/09 |
|---|---|
| Official Contact / Address | |
| of Manufacturing facility | Matthew Young |
| Manager, Quality Assurance and Regulatory Affairs | |
| Children's Medical Ventures | |
| 191 Wyngate Drive | |
| Monroeville, PA 15146 | |
| Phone: 724-387-4012 | |
| Fax: 412-380-8850 | |
| Email: matthew.young@philips.com | |
| Proprietary Name | Oral/Enteral Syringes |
| Common/Usual Name | Gastrointestinal tubes and accessories |
| Classification Reference | 21 CFR 876.5980 |
| Classification | Class II |
| Appropriate Classification Panel | Gastroenterology / Urology |
| Product Code | FPD |
| Predicate Devices | Vygon Corp. Nutrisafe 2 System Transparent Syringes |
| (K060944) | |
| Respironics, Inc. Enteral Only Extension Set (K082654) |
Intended Use/Indications for Use
The Oral/Enteral Syringes is intended for the delivery of liquid medication, formula, and breast milk.
Patient Population/Environment of Use
The patient population is neonates and infants. The environments for use are hospital and home environments by trained caregivers only. The Oral/Enteral Only Syringes is disposable and for single patient use only.
1
K1000 Y9 Page 2 of 2
Premarket Notification 510(k) Tab 5 – 510(K) Summary
I/Enteral Syringes
Substantial Equivalence
This traditional 510(k) submittal demonstrates that the Oral/Enteral Syringes are substantially equivalent to the Respironics, Inc. Enteral Only Extension Set (K082654) and the Vygon Corp. Nutrisafe 2 System Transparent Syringes (K060944).
Design verification tests were performed on the Oral/Enteral Syringes as a result of the risk analysis and product requirements. The following tests were conducted:
- . Volume Measurement Accuracy Testing
- . Enteral Feeding Extension Set Interface Testing
- . Size and Material Inspection
- . Biocompatibility Testing
- . Sterility Testing
- Reliability Inspection .
- . Labeling Inspection
- Environmental Operating Testing .
- . Storage Testing
- . ISTA Testing
Testing Results demonstrated that the Oral/Enteral Syringes meet the required acceptance criteria. Children's Medical Ventures has determined that the Oral/Enteral Syringes are substantially equivalent to the predicate devices.
Device Description
The Oral/Enteral Syringes are intended for the delivery of liquid medication, formula, and breast milk. The syringes incorporate safety connectors that mate with the Respironics Enteral Only Extension Set, but will not mate with Luer lock or Luer slip fittings. The safety connectors prevent inadvertent connection of the enteral system to an IV system or an IV system to the enteral system. The Oral/Enteral Syringe barrels, plungers and end caps are comprised of Polypropylene, and the pistons are comprised of Silicone.
2
Image /page/2/Picture/1 description: The image shows the seal of the Department of Health & Human Services USA. The seal is circular and contains the department's name around the perimeter. In the center of the seal is an emblem that features a stylized caduceus, a symbol often associated with medicine and healthcare. The caduceus has a staff with two snakes winding around it, and a pair of wings at the top.
Food and Drug Administration 10903 New Hampshire Avenue Document Mail Center - WO66-G60 Silver Spring, MD 20993-0002
Philips Children's Medical Ventures c/o Mr. Mark Job Responsible Third Party Official Regulatory Technology Services LLC 1394 25th Street NW BUFFALO MN 55313
JUN 1 4 2010
Re: K100099
Trade/Device Name: Oral/Enteral Syringes Regulation Number: 21 CFR §876.5980 Regulation Name: Gastrointestinal tube and accessories Regulatory Class: II Product Code: FPD Dated: June 3, 2010 Received: June 4, 2010
Dear Mr. Job:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related
3
Page 2 -
adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.html for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address ... http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Janine M. Morris
Acting Director, Division of Reproductive. Abdominal, and Radiological Devices office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use
510(k) Number (if known):
Device Name:
Oral/Enteral Syringes
Intended Use/Indications for Use:
Oral/Enteral Syringes are intended for the delivery of liguid medication, formula, and breast milk.
Patient Population/Environment of Use:
The patient population is neonates and infants. The environments for use are hospital and home environments by trained caregivers only. The Oral/Enteral Syringes are disposable and for single patient use only.
Prescription Use × (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off) Division of Reproductive, Abdominal and Radiological Devices 510(k) Number